期刊文献+

长春新碱不良反应影响因素的研究进展 被引量:2

Influence factors of vincristine's adverse reaction
原文传递
导出
摘要 在儿童肿瘤的治疗中,长春新碱是应用最广泛、疗效最确切的药物之一,但是长春新碱诸多的不良反应限制了其在临床中的应用。近年来研究发现,长春新碱在人种以及个体间有不同的代谢速率,与咪唑类抗真菌药等药物联合使用可能会增强其不良反应。新型给药系统的研究为降低长春新碱的不良反应,提高其生物利用度提供了新思路。 During the treatment of pediatric tumor,vincristine is one of the most widely used and most effective drugs. However,the adverse reactions have limited its clinical application. In recent years,studies have found that the metabolism of vincristine are different in different races and different individuals,and coad-ministration with certain drugs such as imidazoles antifungal drugs may enhance its adverse reaction. Researches on new drug delivery system provide a new idea for reducing the adverse reactions of vincristine and improving its bioavailability.
作者 黄程 马晓莉
出处 《国际肿瘤学杂志》 CAS 2014年第8期574-576,共3页 Journal of International Oncology
关键词 长春新碱 给药系统 不良反应 影响因素 Vincristine Medication systems Adverse reaction Influence factors
  • 相关文献

参考文献9

  • 1Silverman JA, Deitcher SR. Marqibo (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine[J].Cancer Chemother Pharmacol.2013, 71(3):555-564.
  • 2Dennison JB, Jones DR, Renbarger JL, et al. Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes[J].J Pharmacol Exp Ther.2007, 321(2):553-563.
  • 3Dennison JB, Mohutsky MA, Barbuch RJ, et al. Apparent high CYP3A5 expression is required for significant metabolism of vincristine by human cryopreserved hepatocytes[J].J Pharmacol Exp Ther.2008, 327(1):248-257.
  • 4van Schaik RH. CYP450 pharmacogenetics for personalizing cancer therapy[J].Drug Resistance Updates.2008, 11(3):77-98.
  • 5Lange BJ, Bostrom BC, Cherlow JM, et al. Doubledelayedintensi fication improves eventfree survival for children with intermediaterisk acute lymphoblastic leukemia: a report from the Children′s Cancer Group[J].Blood.2002, 99(3):825-833.
  • 6Egbelakin A, Ferguson MJ, MacGill EA, Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia[J]. Pediatr Blood Cancer, 2011, 56(3): 361-367.
  • 7Brūggemann RJ, Alffenaar JW, Blijlevens NM, et al. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents[J].Clin Infect Dis.2009, 48(10):1441-1458.
  • 8冷玲, 佟仲生. 常用化疗药物的脂质体剂型[J]. 国际肿瘤学杂志, 2008, 35(8): 585-587.
  • 9李文静,杨志强,王杏林.硫酸长春新碱脂质体研究进展[J].中国新药杂志,2012,21(13):1479-1484. 被引量:10

二级参考文献40

共引文献9

同被引文献30

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部